Schizophrenia Drug Linked to Pneumonia, Gut Disorders in 25-Year Follow-Up Study
By Huey Freeman Recent research has linked clozapine, a powerful medication for schizophrenia, to an increased risk of mortality associated with pneumonia and severe gastrointestinal complications. Clozapine is the only drug in the United States approved to treat “treatment-resistant schizophrenia,” which affects one in five schizophrenic patients. It was removed from global markets in…
More Stories
PJX Resources (CVE:PJX) Trading 45.5% Higher – Here’s Why
PJX Resources Inc. (CVE:PJX – Get Free Report) shares rose 45.5% on Saturday . The stock traded as high as...
MultiMetaVerse (NASDAQ:MMV) Trading Down 1% – What’s Next?
MultiMetaVerse Holdings Limited (NASDAQ:MMV – Get Free Report) dropped 1% during trading on Thursday . The company traded as low...
Global Partners (NYSE:GLP) Shares Pass Above Two Hundred Day Moving Average – Time to Sell?
Global Partners LP (NYSE:GLP – Get Free Report) shares crossed above its 200-day moving average during trading on Thursday ....
Samfine Creation Holdings Group (NASDAQ:SFHG) Shares Up 19.8% – What’s Next?
Samfine Creation Holdings Group Limited (NASDAQ:SFHG – Get Free Report) shares were up 19.8% on Thursday . The company traded...
Rubicon Technology (NASDAQ:RBCN) Stock Price Passes Above 200 Day Moving Average – What’s Next?
Rubicon Technology, Inc. (NASDAQ:RBCN – Get Free Report)’s share price passed above its 200-day moving average during trading on Thursday...
Bancorp of New Jersey (NYSEAMERICAN:BKJ) Shares Pass Above Two Hundred Day Moving Average – Here’s What Happened
Shares of Bancorp of New Jersey Inc (NYSEAMERICAN:BKJ – Get Free Report) crossed above its two hundred day moving average...